A female trial participant in England had showed symptoms severe

The trials have not resumed in any other country. News reports in the United States suggested that the “highest levels of NIH” were very “concerned” around the lack of clarity over what exactly had happened to the unnamed trial participant. AstraZeneca, whose vaccine is being developed in collaboration with Oxford University, has not specified the exact condition the patient was found suffering from, or the findings of the assessment on her case.

You May Have Missed